MXCT vs WRB · rev $38.6M vs P/E 17, $27.12B cap
MaxCyte Inc (MXCT) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
WRB does not have a complete income-statement cache yet.
MXCT currently screens at market cap $124.3M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the MXCT and WRB stock pages for the full models.
Not investment advice.